Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunotherapy in MSI/dMMR Tumors in Perioperative Setting.

NCT04795661 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT04795661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04795661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunotherapy in MSI/dMMR Tumors in Perioperative Setting.
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 18, 2021
Completion date
October 31, 2029
Enrollment
240 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

localized resectable tumor, msi/dmmr